rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

iRadimed Corporation

IRMD · Nasdaq

Health CareMedical DevicesSetting up

IRMD stood above a rising 150-day average in 29 of the last 52 weekly readings, and has been out of that trend for the last 13 weeks. It is 2.9% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 13
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$31.4M
Officials’ trades on record
0
Institutions holding
199 (-10)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 29 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$7.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months47
Buyers · sellers0 · 5
WhoDidSharesTraded
Monty K. AllenDirectorsold1,014at $86.443 Sep 2026filed 8 Sep 2026
Monty K. AllenDirectorsold405at $86.353 Sep 2026filed 8 Sep 2026
Hilda Frederique Scharen-GuivelDirectorsold1,766at $95.004 Jun 2026filed 4 Jun 2026
Hilda Frederique Scharen-GuivelDirectorsold1,234at $95.004 Jun 2026filed 4 Jun 2026
Roger E. SusiCEO, President, Chairmansold400at $88.681 Jun 2026filed 2 Jun 2026
Roger E. SusiCEO, President, Chairmansold775at $89.791 Jun 2026filed 2 Jun 2026
Roger E. SusiCEO, President, Chairmansold401at $91.081 Jun 2026filed 2 Jun 2026
Roger E. SusiCEO, President, Chairmansold924at $91.911 Jun 2026filed 2 Jun 2026
Roger E. SusiCEO, President, Chairmansold2,167at $91.8527 May 2026filed 28 May 2026
Roger E. SusiCEO, President, Chairmansold333at $92.6127 May 2026filed 28 May 2026
Roger E. SusiCEO, President, Chairmansold3,111at $91.8126 May 2026filed 28 May 2026
Roger E. SusiCEO, President, Chairmansold1,889at $92.9326 May 2026filed 28 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders199-10 on the quarter
New · exited21 · 32
Reported value$705.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 2026967,825$92.5M+380.0%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLCadded · filed 13 Aug 2026396,982$37.9M+47,666+13.6%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026394,412$37.7M-46,300−10.5%
Copeland Capital Management, LLCadded · filed 4 Aug 2026391,860$37.4M+32,535+9.1%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026364,937$34.9M+6,317+1.8%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026290,109$27.7M+3,546+1.2%
Nine Ten Capital Management LLCreduced · filed 14 Aug 2026256,562$24.5M-77,926−23.3%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026229,340$21.9M+3,194+1.4%
STATE STREET CORPadded · filed 7 Aug 2026221,512$21.2M+16,984+8.3%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026214,151$20.5M+16,206+8.2%
31 Mar 2023 – 30 Jun 2026
74139204Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Joe E. Kiani Company insiderDirector · last 23 Sep 20260 · 0
Monty K. Allen Company insiderDirector · last 3 Sep 20260 · 21
John Glenn Company insiderCFO · last 20 Jun 20260 · 3
Hilda Frederique Scharen-Guivel Company insiderDirector · last 4 Jun 20260 · 1
Roger E. Susi Company insiderCEO, President, Chairman · last 1 Jun 20265 · 171
Jeff Chiprin Company insiderChief Commercial Officer · last 3 Mar 20260 · 0
James B. Hawkins Company insiderDirector · last 11 Dec 20251 · 26
Anthony Vuoto Company insiderDirector · last 11 Dec 20240 · 9
Christopher K. Scott Company insiderCFO & Secretary · last 11 Feb 20220 · 8
Louis S. Waldman Company insiderOther · last 24 Jul 20200 · 16
Leslie L. McDonnell Company insiderOther · last 28 May 20200 · 0
Brent Johnson Company insiderExec. VP of WW Sales and Mktg · last 10 Apr 20200 · 157

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202576.7%
Operating profit marginFY 2025 · to 31 Dec 202531.2%
Free cash flow marginFY 2025 · to 31 Dec 202520.5%
Return on capital employedFY 2025 · to 31 Dec 202526.5%
Cash conversionFY 2025 · to 31 Dec 2025111%
Research spendFY 2025 · to 31 Dec 20253.5%
Share count trendFY 2025 · to 28 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$51.2M
Free cash flowFY 2025 · to 31 Dec 2025$17.2M

Analyst forecasts

No analyst forecasts yet.